Mobiosense - Taipei

HERO, a product developed by Mobiosense, provides an innovative solution to the limitations of conventional troponin tests. Unlike its predecessors, HERO is highly sensitive, portable, and enables hospitals to accurately diagnose heart attack within three hours. Moreover, HERO can be used to assess patients in ambulances, significantly reducing overcrowding in emergency rooms and allowing for expedited care. In comparison, conventional troponin tests are not sensitive enough and require multiple tests over 12 hours to detect a heart attack, making HERO an invaluable tool in the fight against cardiovascular disease.